Healthcare provider profile · identity verified

Devin Kent Higgins, D.O.

Family Practice · WINDSOR, CO · NPI 1346689213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	288	85
Levothyroxine Sodium	Levothyroxine Sodium	217	64
Lisinopril	Lisinopril	192	57
Rosuvastatin Calcium	Rosuvastatin Calcium	136	45
Gabapentin	Gabapentin	125	41
Losartan Potassium	Losartan Potassium	123	40
Amlodipine Besylate	Amlodipine Besylate	113	33
Tamsulosin Hcl	Tamsulosin Hcl	113	33
Omeprazole	Omeprazole	103	38
Metoprolol Succinate	Metoprolol Succinate	88	26
Metformin Hcl	Metformin Hcl	85	30
Hydrochlorothiazide	Hydrochlorothiazide	80	24
Trazodone Hcl	Trazodone Hcl	72	23
Furosemide	Furosemide	70	28
Metformin Hcl Er	Metformin Hcl	68	19
Allopurinol	Allopurinol	67	21
Simvastatin	Simvastatin	63	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	12
Montelukast Sodium	Montelukast Sodium	48	14
Finasteride	Finasteride	47	18
Fluoxetine Hcl	Fluoxetine Hcl	46	12
Meloxicam	Meloxicam	46	20
Mounjaro	Tirzepatide	45	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	45	13
Ozempic	Semaglutide	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	12
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Pravastatin Sodium	Pravastatin Sodium	35	12
Alendronate Sodium	Alendronate Sodium	34	12
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	11
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Eliquis	Apixaban	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Famotidine	Famotidine	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	19
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Celecoxib	Celecoxib	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	11
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Potassium Chloride	Potassium Chloride	24	12
Terbinafine Hcl	Terbinafine Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Azithromycin	Azithromycin	22	22
Bupropion Xl	Bupropion Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	16
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Methylprednisolone	Methylprednisolone	19	18
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	11
Atenolol	Atenolol	18	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Prednisone	Prednisone	14	13
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Cephalexin	Cephalexin	13	12
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Glipizide	Glipizide	11	suppressed
Levofloxacin	Levofloxacin	11	11
Mirtazapine	Mirtazapine	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error